Literature DB >> 10215438

Prediction of the survival of patients with advanced ovarian cancer according to a risk model based on a scoring system.

D Schneider1, R Halperin, D Halperin, I Bukovsky, E Hadas.   

Abstract

PURPOSE OF INVESTIGATION: The aim of the study was to devise a scoring system based on significantly prognostic parameters which might predict the survival time for each individual patient.
METHODS: The study group included 40 patients with stage III or IV invasive ovarian cancer, operated on between 1987 and 1994. Different preoperative and intraoperative parameters were examined and their impact on survival was assessed using the Kaplan-Meier method. Survival rates were compared by the log rank test. The parameters, which have been found to be significant prognostic factors, were incorporated into the final risk model, based on a scoring system. The scores were given according to the cut-off point of each prognostic parameter. A correlation coefficient was calculated from the survival curve, representing the combined scores of individual patients versus their survival.
RESULTS: From all studied parameters, only gravidity, the stage of ovarian cancer and the preoperative levels of LDH and CA-125 were demonstrated to have a significant impact on survival. On the basis of these four parameters a scoring system was devised. The scores were given considering the cut-off level of each parameter: gravidity < or = 2 versus > 2; stage of the cancer - IIIA, IIIB and stage IIIC versus stage IV; LDH level < or = 240 versus > 240 U/L; CA-125 < or = 100 versus > 100 U/ml. The average of the combined scores representing the four parameters was the final risk factor, which was plotted against the survival of each individual patient. A correlation coefficient of -0.99 was found.
CONCLUSIONS: Our data suggest that the survival of each individual patient with advanced ovarian cancer could be predicted quite accurately considering our risk model based on a scoring system which incorporates four preoperative and intraoperative parameters. This scoring system needs to be validated by larger prospective trials.

Entities:  

Mesh:

Year:  1998        PMID: 10215438

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN: 0392-2936            Impact factor:   0.196


  4 in total

1.  Does Aquaporin-1 expression have clinical significance in serous epithelial ovarian cancer?

Authors:  Mustafa Kemal Takal; Cem Baykal; Eralp Başer; Mustafa Derda Kaya; Polat Dursun; Ozlem Ozen; Asuman Nihan Haberal; Ali Ayhan
Journal:  J Turk Ger Gynecol Assoc       Date:  2013-09-01

2.  Serum lactate dehydrogenase and survival following cancer diagnosis.

Authors:  Wahyu Wulaningsih; Lars Holmberg; Hans Garmo; Håkan Malmstrom; Mats Lambe; Niklas Hammar; Göran Walldius; Ingmar Jungner; Tony Ng; Mieke Van Hemelrijck
Journal:  Br J Cancer       Date:  2015-10-15       Impact factor: 7.640

3.  Predictors of Survival Outcomes After Primary Treatment of Epithelial Ovarian Cancer in Lagos, Nigeria.

Authors:  Kehinde Sharafadeen Okunade; Adebola A Adejimi; Ephraim O Ohazurike; Omolola Salako; Benedetto Osunwusi; Muisi A Adenekan; Aloy O Ugwu; Adaiah Soibi-Harry; Olayemi Dawodu; Adeyemi A Okunowo; Rose I Anorlu; Jonathan S Berek
Journal:  JCO Glob Oncol       Date:  2021-01

4.  Predictors of early mortality risk in patients with epithelial ovarian cancer.

Authors:  Kehinde S Okunade; Sarah John-Olabode; Ephraim O Ohazurike; Adaiah Soibi-Harry; Benedetto Osunwusi; Rose I Anorlu
Journal:  Health Sci Rep       Date:  2022-07-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.